Correlation Between Avadel Pharmaceuticals and 6325C0EB3

Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and 6325C0EB3 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and 6325C0EB3 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and NAB 1887 12 JAN 27, you can compare the effects of market volatilities on Avadel Pharmaceuticals and 6325C0EB3 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of 6325C0EB3. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and 6325C0EB3.

Diversification Opportunities for Avadel Pharmaceuticals and 6325C0EB3

-0.78

Correlation Coefficient

Avadel Pharmaceuticals  6325C0EB3

Pay attention - limited upside

The 3 months correlation between Avadel and 6325C0EB3 is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and NAB 1887 12 JAN 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NAB 1887 12 and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with 6325C0EB3. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NAB 1887 12 has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and 6325C0EB3 go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and 6325C0EB3

Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to under-perform the 6325C0EB3. In addition to that, Avadel Pharmaceuticals is 6.89 times more volatile than NAB 1887 12 JAN 27. It trades about -0.02 of its total potential returns per unit of risk. NAB 1887 12 JAN 27 is currently generating about 0.11 per unit of volatility. If you would invest  9,027  in NAB 1887 12 JAN 27 on September 30, 2024 and sell it today you would earn a total of  480.00  from holding NAB 1887 12 JAN 27 or generate 5.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	26.27%
Values	Daily Returns

Avadel Pharmaceuticals PLC  vs.  NAB 1887 12 JAN 27

Avadel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

NAB 1887 12

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NAB 1887 12 JAN 27 has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, 6325C0EB3 is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Avadel Pharmaceuticals and 6325C0EB3

The main advantage of trading using opposite Avadel Pharmaceuticals and 6325C0EB3 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, 6325C0EB3 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 6325C0EB3 will offset losses from the drop in 6325C0EB3's long position.

The idea behind Avadel Pharmaceuticals PLC and NAB 1887 12 JAN 27 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.